Myanmar Health Sciences Research Journal
Next Prev
Aims of MHSR Journal
  • To serve as an important medium for the publication of original research in the field of medical science and health research, thus filling gaps in health knowledge for effective utilization of research findings
  • To impart current medical knowledge and updated scientific information obtained from research to health professionals for better and appropriate health care management
  • To disseminate recent basic, applied and social research findings among health personnel of different strata for enhancing worldwide health development


Archives   2017

Myanmar   Health   Sciences   Research   Journal

Volume   29,  Number   1

TITLE:   Multidrug-resistant Mycobacterium tuberculosis Strains in Myanmar Patients
AUTHOR:   Thanda Tun, Kyi Kyi Thinn, Khin Saw Aye, Win Win Yee, Naw Eh Khu Se, Khin Zaw Latt & Thandar Lwin
SOURCE:   Myanmar Health Sciences Research Journal, Vol. 29, No. 1, 2017
ABSTRACT:   Myanmar is one of the high MDR-TB burden countries globally. The aim of this study was to provide genetic information of MDR-TB strains from Myanmar. A total of 139 high-positive sputum samples (i.e., AFB grade 2+ or 3+) from MDR-TB suspected cases which were referred to National TB Reference Laboratory, Yangon during 2012-2013 were included. GenoType MTBDRplus assay was used to detect resistance to rifampicin and isoniazid, and results were compared with phenotypic Lowenstein-Jensen proportion method at National TB Reference Laboratory, Yangon. Genotypes were also identified by spoligotyping method. The most common rifampicin resistance mutation was S531L (67.5%) in the rpoB gene and the most prevalent isoniazid resistance mutation was S315T (90.4%) in the katG gene. There was high agreement (kappa=0.934) between the MTBDRplus assay and phenotypic susceptibility results in detecting MDR-TB. The inhA C15T mutation was more likely to occur in isoniazid mono-resistant cases than in MDR-TB cases (p=0.038). Beijing genotype was predominantly identified in 76.4% of strains (55/72). Strains belonging to Beijing geno-types are significantly associated with MDR-TB (p=0.001) as well as resis-tance to isoniazid, rifampicin, streptomycin and ethambutol (all p<0.05). The katG S315T mutation was more likely to develop in strains of Beijing genotype (p=0.009). This study provides relevant data which can be applied for the development of new and better tools (diagnostics, therapeutics, vaccines) for effective measures in the control of drug-resistant tuberculosis in the country. It also gives information on the general anti-TB drug resistance status in Myanmar patients.
SUBJECT HEADINGS:   Multidrug resistant, Tuberculosis, Myanmar, Genotype, Mutation
FULL TEXT:  

Back to Articles

Vision : Achieving a healthier nation through application of research findings          Mission Statement : To Develop and promote solutions to the major health problems of Myanmar